Share This Page

Maudes Awards

Support & Insight for the Autumn of Life

Drugs

Woman caring for her mother with dementia

Getting Dementia Patients to Take Their Meds

June 25, 2024 No Comments

Grandma hates taking her medications. With her dementia, she ends up asking 10 different times why she has to take it! What should I do?

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Seroquel-quetiapine Prescriptions Drop 15% After Dementia Warning

May 22, 2024 3 Comments

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval

May 16, 2024 No Comments

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

Leqembi for Alzheimer’s: Patient and Doctor Hopeful After First 6 Months

March 18, 2024 No Comments

The first doses of the newly approved Alzheimer’s drug “Leqembi” were administered in Louisville. More than 100 people have signed up since then. See why.

Aduhelm for Alzheimer’s Discontinued. Is Leqembi Any Better?

February 8, 2024 No Comments

Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.

Aduhelm for Alzheimer’s Discontinued. Is Leqembi Any Better?

February 6, 2024 No Comments

Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.

Leqembi: An Alzheimer’s Drug Worth Rooting For?

November 16, 2023 No Comments

At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease. Only five Alzheimer’s treatments have been approved by the FDA up until a decade ago, and this is only the second to address the progression of the disease.

Adlarity has 7 Advantages over Donepezil Tablets

October 22, 2023 No Comments

FDA-approved ADLARITY is the once-weekly donepezil patch. See how it compares to donepezil / Aricept / Ebixa tablets for Alzheimer’s.

You Are Not Alone: Dealing with Lewy Body Dementia

July 17, 2025

All a caregiver for Lewy Body Dementia needs to know, from symptoms to diagnosis to care for their loved one and themselves, for the entire caregiving journey. Part memoir and part help book.

Opioids & Dementia: New Study Finds Strong Link

July 16, 2025

Does pain relief risk cognitive cost? A major new study of almost 200,000 people says yes—and the price may be higher than we thought.

kid, coffee, cup, breakfast, tiny, kids, small, coffee, coffee, coffee, coffee, coffee, kids

Big Cup, Little Man: Picking Up the Earliest Signs of Alzheimer’s

July 15, 2025

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.